Respiratory Inhaler Market to Grow, Led by North America & Asia with AstraZeneca, GSK, Teva innovations
The global Respiratory Inhaler Devices Market is projected to reach USD 68.1 billion by 2036, rising from USD 38.0 billion in 2026 at a CAGR of 6.0%. This